Breaking News

Superdrug has quietly made history by becoming the first UK provider to offer the Wegovy pill following MHRA approval, marking a genuine shift in how weight loss treatment is accessed in Britain. For the millions who struggle with injections or simply prefer tablets, this changes the conversation. Experts say this is just the beginning of a competitive oral weight loss market that could reshape private treatment in the UK.

Eli Lilly has announced plans to bring its weight loss pill to Europe and the UK by late 2026 or early 2027. For the millions of UK patients who are curious about obesity treatment but unwilling to use injections, this could be a genuine game-changer. Here is everything you need to know before the hype takes over.

A daily pill that works like Ozempic but without injections is now being assessed for NHS use in England and Wales. NICE is scheduled to meet in July 2026 to evaluate orforglipron, sold under the brand name Foundayo. Here is everything UK patients need to know before the reviews are complete.

The MHRA has approved an oral semaglutide pill for weight loss — a genuine first for the UK. If you have been waiting for a needle-free alternative to Wegovy injections, this is the news you have been hoping for. Here is everything you need to know before spending a penny.

A major new survey has found that households using GLP-1 weight loss jabs are spending significantly less on food each year — suggesting the treatments may partially pay for themselves. With 1.9 million UK adults now using these medications, the financial picture is changing fast. Here is what the findings mean if you are considering treatment.

A new experimental drug called apitegromab could help people taking Mounjaro preserve more muscle while losing weight, according to research published in Nature Medicine. The early study found participants retained significantly more lean muscle mass while achieving similar weight loss, raising hopes that future obesity treatments may help protect muscle as well as reduce body fat.

A pill version of Wegovy — the popular weight loss injection — is days away from approval in the UK. It costs less than the jab and removes the needle barrier that puts millions of people off treatment. Here is everything you need to know before it lands.

New trial data shows retatrutide helped people lose nearly a third of their body weight on average — results that rival bariatric surgery. But the drug is not approved in the UK, and experts say realistic access is still at least 18 months away. Here is everything you need to know right now.

A new injectable weight loss treatment called retatrutide has produced results that have genuinely surprised researchers. In a major Phase 3 trial, participants lost an average of 28.3% of their body weight — more than any approved jab has achieved so far. Here is what the results mean for UK women waiting for the next generation of treatments.

New phase 3 trial results show a drug called retatrutide helped people lose more weight than any medicine ever tested — nearly matching what bariatric surgery achieves. It is not available in the UK yet, and experts say it won't be for at least another year. Here is everything you need to know right now.